ARV-471

Other Medications

Description

ARV-471 is currently being studied in clinical trials for certain types of colorectal cancer. The trials are in Phase 2, which means they are testing the drug in a larger group of patients to see how well it works and what the side effects are. These trials are looking at ARV-471 in patients whose tumors have specific characteristics, including HER2 mutations or lack of HER2 expression. ARV-471 is being tested both alone and in combination with other cancer drugs. The goal of these trials is to determine the best dose and how effective ARV-471 is in treating this type of cancer.

Mechanism of Action

ARV-471 is an investigational drug. The specific way it works (its mechanism of action) is being studied in clinical trials. It is being evaluated in patients with specific tumor characteristics, such as HER2 mutations or lack of HER2 expression, suggesting it may target pathways related to these features.

Side Effects

ARV-471 is an investigational drug And its side effects are still being evaluated in ongoing clinical trials. The specific side effects will depend on the dose and whether it is used alone or in combination with other drugs. As more data becomes available from the trials A clearer picture of the potential side effects will emerge.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT04606446 Phase 2

Recruiting

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

United States, Australia, China, Japan, South Korea

Quick Info

Category	Other Medications
Clinical Trials	1

View Clinical Trials Back to Drug Glossary

Related Medications

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.